Cited by 91Pancreatic function and diabetesGenomics and Rare DiseasesPituitary Gland Disorders and Treatments

Novel FOXA2 mutation causes Hyperinsulinism, Hypopituitarism with Craniofacial and Endoderm-derived organ abnormalities

Open access
Giri, Dinesh, Vignola, Maria Lillina, Gualtieri, Angelica, Scagliotti, Valeria, McNamara, Paul, Peak, Matthew, Didi, Mohammed, Gaston-Massuet, Carles +1 more·2017·Human Molecular Genetics

Abstract

Congenital hypopituitarism (CH) is characterized by the deficiency of one or more pituitary hormones and can present alone or in association with complex disorders. Congenital hyperinsulinism (CHI) is a disorder of unregulated insulin secretion despite hypoglycaemia that can occur in isolation or as part of a wider syndrome. Molecular diagnosis is unknown in many cases of CH and CHI. The underlying genetic etiology causing the complex phenotype of CH and CHI is unknown. In this study, we identified a de novo heterozygous mutation in the developmental transcription factor, forkhead box A2, FOXA2 (c.505T>C, p.S169P) in a child with CHI and CH with craniofacial dysmorphic features, choroidal coloboma and endoderm-derived organ malformations in liver, lung and gastrointestinal tract by whole exome sequencing. The mutation is at a highly conserved residue within the DNA binding domain. We demonstrated strong expression of Foxa2 mRNA in the developing hypothalamus, pituitary, pancreas, lungs and oesophagus of mouse embryos using in situ hybridization. Expression profiling on human embryos by immunohistochemistry showed strong expression of hFOXA2 in the neural tube, third ventricle, diencephalon and pancreas. Transient transfection of HEK293T cells with Wt (Wild type) hFOXA2 or mutant hFOXA2 showed an impairment in transcriptional reporter activity by the mutant hFOXA2. Further analyses using western blot assays showed that the FOXA2 p.(S169P) variant is pathogenic resulting in lower expression levels when compared with Wt hFOXA2. Our results show, for the first time, the causative role of FOXA2 in a complex congenital syndrome with hypopituitarism, hyperinsulinism and endoderm-derived organ abnormalities.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/hmg/ddx318

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The most frequently identified mutations associated with multiple pituitary hormone deficiency are in PROP1.

    “The most frequently identified mutations associated with MPHD are in PROP1 [27, 34-37].”

    From 2018 European Thyroid Association (ETA) Guidelines on the Diagnosis and Management of Central Hypothyroidism (2018) · cites this paper as [37]

    The Introduction (page unavailable) lists PROP1 among genes associated with congenital hypopituitarism, and reference 7 identifies a study of PROP1 mutations causing combined pituitary hormone deficiency. Neither passage says PROP1 mutations are the most frequently identified in patients with multiple pituitary hormone deficiency. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Giri, D., Vignola, M. L., Gualtieri, A., Scagliotti, V., McNamara, P., Peak, M., Didi, M., Gaston-Massuet, C., & Senniappan, S.
Affiliations
  • University of Liverpool (GB)
  • Queen Mary University of London (GB)
  • Alder Hey Children's NHS Foundation Trust (GB)
  • Centre for Endocrinology, William Harvey Research Institute, Barts & the London School of Medicine, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK
Corresponding author
Senniappan, Senthil
Venue
Human Molecular Genetics
Published
2017-08-24
Volume
26
Issue
22
Pages
4315-4326
ISSN
  • 0964-6906 (ISSN-L)
  • 1460-2083
OpenAlex
W2807274776
Cited by
91
References
55
Citations by year
2026: 6 · 2025: 6 · 2024: 5 · 2023: 9 · 2022: 17 · 2021: 13 · 2020: 8 · 2019: 16 · 2018: 9 · 2017: 1
FWCI
9.53
Type
journal article
Language
en
Open access
Locations
  • Human Molecular Genetics (publishedVersion)
  • PubMed (publishedVersion)
  • Queen Mary Research Online (Queen Mary University of London) (submittedVersion)
Funders
  • MRC
  • Action Medical Research (GN2272)
  • University of Liverpool (Jxg 70001)
  • CRF
Topics
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
Keywords
FOXA2, congenital hyperinsulinism, congenital hypopituitarism, de novo mutations, craniofacial dysmorphism, choroidal coloboma, liver malformation, lung malformation, gastrointestinal tract malformations, DNA-binding domain, transcription factors, hypothalamus, pancreas, pathogenicity assessment, hypoglycemia
MeSH terms
Adult, Animals, Child, Preschool, Female, Humans, Hyperinsulinism, Hypopituitarism, Male, Mutation, Pregnancy, Transcription Factors, Transfection, Craniofacial Abnormalities, Mice, Hepatocyte Nuclear Factor 3-beta, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review